format-version: 1.2
date: 28:11:2018 21:44
auto-generated-by: https://github.com/pharmacome/terminology/blob/master/export/obo.py

[Term]
id: HBP:HBP00001
name: microtubule-binding region
def: "The motif in the MAPT protein where microtubule binding repeats" [pmid:18500754, pmid:2516729]
synonym: "MTBR" EXACT []
xref: interpro:IPR001084
part_of: HBP:HBP00188 ! assembly domain

[Term]
id: HBP:HBP00002
name: tubulin-binding repeat 1
def: "position 569_591 of canonical isoform of MAPT protein" [pmid:18500754]
synonym: "MTBR R1" EXACT []
synonym: "R1" EXACT []
xref: BEL:"p(HGNC:MAPT, frag(569_591))"
part_of: HBP:HBP00001 ! microtubule-binding region

[Term]
id: HBP:HBP00003
name: tubulin-binding repeat 2
def: "position 592_621 of canonical isoform of MAPT protein" [pmid:18500754]
synonym: "MTBR R2" EXACT []
synonym: "R2" EXACT []
xref: BEL:"p(HGNC:MAPT, frag(592_621))"
part_of: HBP:HBP00001 ! microtubule-binding region

[Term]
id: HBP:HBP00004
name: tubulin-binding repeat 3
def: "position 623_653 of canonical isoform of MAPT protein" [pmid:18500754]
synonym: "MTBR R3" EXACT []
synonym: "R3" EXACT []
xref: BEL:"p(HGNC:MAPT, frag(623_653))"
part_of: HBP:HBP00001 ! microtubule-binding region

[Term]
id: HBP:HBP00005
name: tubulin-binding repeat 4
def: "position 654_685 of canonical isoform of MAPT protein" [pmid:18500754]
synonym: "MTBR R4" EXACT []
synonym: "R4" EXACT []
xref: BEL:"p(HGNC:MAPT, frag(654_685))"
part_of: HBP:HBP00001 ! microtubule-binding region

[Term]
id: HBP:HBP00006
name: Tau aggregates
def: "Tau (MAPT) in its aggregated form (as Paired Helical Filaments (PHFs) or Straight Filaments (SF)) contains 5–9 moles of phosphate/ mole of the protein, defining it as hyper phosphorylated" [pmc:PMC2633703]
is_a: HBP:HBP00178 ! protein aggregates

[Term]
id: HBP:HBP00007
name: hyperphosphorylation
def: "An excessive phosphorylation (see GO:0006468)" [pmid:22710920]

[Term]
id: HBP:HBP00008
name: GAL80TS
def: "temperature-sensitive allele of GAL80 (tub-GAL80TS)" [pmc:PMC3073608]

[Term]
id: HBP:HBP00009
name: Tau oligomers
def: "CAST is known to prevent oligomerization of Tau (Rao et al., 2014) and α-synuclein (Diepenbroek et al. 2014) and inhibit reactive gliosis (Rao et al., 2008)" [pmc:PMC4828294]

[Term]
id: HBP:HBP00010
name: LY293002
def: "a specific PI3-kinase inhibitor" [pmid:21329734]

[Term]
id: HBP:HBP00011
name: LPLI
def: "Low-power laser irradiation (LPLI) is a non-damage physical therapy" [pmid:20333643]
synonym: "Low-power laser irradiation" EXACT []

[Term]
id: HBP:HBP00012
name: Chronic cerebral hypoperfusion
def: "Chronic cerebral hypoperfusion (CCH) is one of the causes of vascular dementia (VaD) and is also an etiological factor for Alzheimer's disease (AD)" [pmid:24575038]
synonym: "CCH" EXACT []

[Term]
id: HBP:HBP00013
name: Mori Fructus ethanol extract
def: "ethanol extracted from Mori Fructus, a well-known traditional herbal medicine, food, and dietary supplement" [pmid:26068423]
synonym: "ME" EXACT []

[Term]
id: HBP:HBP00014
name: tunneling nanotubes
def: "filamentous-actin-containing membranous structures that bridge and connect cells" [pmid:27809932]
synonym: "membrane nanotube" EXACT []
synonym: "TNT" EXACT []

[Term]
id: HBP:HBP00015
name: amyloidogenesis 
def: "production of amyloid" [pmid:24653673]

[Term]
id: HBP:HBP00016
name: alpha-synuclein aggregates
def: "alpha-synuclein (SNCA) aggregate in fibrillar or oligomeric forms, usually found in Lewy bodies" [pmid:23254192]
is_a: HBP:HBP00178 ! protein aggregates

[Term]
id: HBP:HBP00017
name: huntingtin aggregates
def: "huntingtin (HTT) protein fragments aggregations" [pmid:12747895]
is_a: HBP:HBP00178 ! protein aggregates

[Term]
id: HBP:HBP00018
name: amyloid-beta aggregates
def: "aggregation of amyloid-beta fragments of the APP protein" [pmid:23484434]
is_a: HBP:HBP00178 ! protein aggregates

[Term]
id: HBP:HBP00019
name: SEN-1269
def: "A tau aggregation inhibitor" [pmid:23484434]
xref: pubchem.compound:46835756

[Term]
id: HBP:HBP00020
name: MLS000034832
def: "A tau aggregation inhibitor" [pmid:23484434]
xref: pubchem.compound:647821

[Term]
id: HBP:HBP00021
name: caprospinol
def: "A tau aggregation inhibitor" [pmid:23484434]
xref: drugbank:DB05263

[Term]
id: HBP:HBP00022
name: amyloid-beta oligomers
def: "Small aggregates of amyloid-beta" [pmid:24918635, pmid:29196815]

[Term]
id: HBP:HBP00023
name: amyloid-beta 42 oligomers
def: "Amyloid-beta oligomers composed specifically of amyloid-beta 42" [pmid:24918635]

[Term]
id: HBP:HBP00024
name: APP C-terminally truncated carboxyl-terminal fragments
def: "C-terminally truncated carboxyl-terminal fragments (CTFs) of APP" [pmid:15491160]

[Term]
id: HBP:HBP00025
name: A2B5 antigen
def: "A2B5 antigen is a cell surface ganglioside epitope expressed on developing thymic epithelial cells, oligodendrocyte progenitors, and neuroendocrine cells." [pmid:1497614]

[Term]
id: HBP:HBP00026
name: neutral sphingomyelinase
def: "Sphingomyelin phosphodiesterase (EC 3.1.4.12, also known as neutral sphingomyelinase, sphingomyelinase, or SMase) is a hydrolase enzyme that is involved in sphingolipid metabolism reactions." [pmid:19519303]

[Term]
id: HBP:HBP00027
name: Neurodegeneration
def: "Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes." [pmid:20202123, pmid:12387894]

[Term]
id: HBP:HBP00028
name: amyloid-beta derived diffusible ligands
def: "soluble oligomeric forms of the amyloid beta peptide known as amyloid-derived diffusible ligands (ADDLs) are the toxic species responsible for neurodegeneration associated with Alzheimer's disease." [pmid:19188609]
synonym: "ADDL" EXACT [pmid:16712494]

[Term]
id: HBP:HBP00029
name: Hyperamylinemia
def: "increased secretion of the pancreatic hormone amylin" [pmid:23794448]

[Term]
id: HBP:HBP00030
name: APOE e4
def: "APOE e4 is a variant of APOE, it's APOE-ε4 (arg112, arg158)." [pmid:22701550]

[Term]
id: HBP:HBP00031
name: N-AcGIP
def: "N-AcGIP is agonist of GIP" [pmid:18234983]

[Term]
id: HBP:HBP00032
name: Pro3-GIP
def: "Pro3-GIP is agonist of GIP" [pmid:18234983]

[Term]
id: HBP:HBP00033
name: PI3K-Akt signaling pathway
def: "PI3K-Akt signaling pathway is an intracellular signaling pathway important in regulating the cell cycle.It is described in KEGG." [pmid:22013558]

[Term]
id: HBP:HBP00035
name: Argyrophilic Grain Disease
def: "Argyrophilic grain disease (AGD) is an under-recognized, distinct, highly frequent sporadic tauopathy, with a prevalence reaching 31.3% in centenarians." [pmid:15658002]
synonym: "AGD" EXACT []

[Term]
id: HBP:HBP00036
name: granulovacuolar degeneration
def: "Granulovacuolar degeneration (GVD) is one of the pathological hallmarks of Alzheimer's disease (AD), and it is defined as electron-dense granules within double membrane-bound cytoplasmic vacuoles." [pmid:17455299]
synonym: "GVD" EXACT []

[Term]
id: HBP:HBP00037
name: mitochondrial dysfunction
def: "mitochondria function disorder" [pmid:19885299]

[Term]
id: HBP:HBP00038
name: amyloid-beta fibrils
def: "Insoluble fibrous protein aggregates exhibiting beta sheet structure." [pmid:19158505]

[Term]
id: HBP:HBP00039
name: AG73
def: "a peptide derived from mouse laminin alpha 1 protein (seq:RKRLQVQLSIRT, chain:2719–2730)" [pmid:20615691]
xref: BEL:"p(MGI:Lama1, frag(2719_2730))"

[Term]
id: HBP:HBP00040
name: Notch intracellular domain
def: "Notch intracellular domain is the intracellular region of notch receptor." [pmid:20883690]

[Term]
id: HBP:HBP00041
name: YENPTY endocytosis motif (APP)
def: "YENTY is the endocytosis motif of Amyloid precursor protein." [pmid:18650430]
synonym: "YENPTY" EXACT []

[Term]
id: HBP:HBP00042
name: sAPP-beta
def: "Soluble amyloid precursor protein" [pmid:21606494]
synonym: "soluble amyloid precursor protein" EXACT []

[Term]
id: HBP:HBP00043
name: growth factor
def: "A growth factor is a naturally occurring substance capable of stimulating cellular growth, proliferation, healing, and cellular differentiation. Usually it is a protein or a steroid hormone. Growth factors are important for regulating a variety of cellular processes." [pmid:14678766]

[Term]
id: HBP:HBP00044
name: 3R tau
def: "Tau isoforms containing 3 tubulin binding repeats" [pmid:23407988]

[Term]
id: HBP:HBP00045
name: 4R tau
def: "Tau isoforms containing 4 tubulin binding repeats" [pmid:23407988]

[Term]
id: HBP:HBP00046
name: VQIINK motif
def: "A hexapeptide motif located in the R2, that promotes the formation of PHF" [pmid:17493042]
synonym: "PHF6* " EXACT [pmid:25775228]
part_of: HBP:HBP00003 ! tubulin-binding repeat 2

[Term]
id: HBP:HBP00047
name: VQIVYK motif 
def: "A hexapeptide motif located in the R3, that promotes the formation of PHF" [pmid:17493042]
synonym: "PHF6" EXACT [pmid:25775228]
part_of: HBP:HBP00004 ! tubulin-binding repeat 3

[Term]
id: HBP:HBP00048
name: ghost tangles
def: "Extracellular NFT remains after neuron death, considered to be the last stage of NFT-related pathological activity." [pmid:23407988, pmid:8431763]
is_a: GO:GO:0097418 ! neurofibrillary tangle

[Term]
id: HBP:HBP00049
name: pretangles
def: "Pretangles are cytoplasmic tau immunoreactivity in neurons without apparent formation of fibrillary structures. In Alzheimer disease, such tau deposition is considered to represent a premature state prior to fibril formation (AD-pretangles), later to form neurofibrillary tangles and finally ghost tangles." [pmid:23407988, pmid:24612177]
is_a: GO:GO:0097418 ! neurofibrillary tangle

[Term]
id: HBP:HBP00050
name: projection domain
def: "Corresponding roughly to the N-terminal part of the tau molecule, consisting mainly of acidic residues and containing two distinct alternatively spliced N-terminal inserts." [pmid:17493042, pmid:28386764]
synonym: "MAP2/Tau projection" EXACT []
xref: interpro:IPR013588

[Term]
id: HBP:HBP00051
name: RAC1b
def: "A constitutively active splicing isoform of RAC1 (Ras-related C3 botulinum toxin substrate 1), first identified in breast and colon cancer." [pmid:22142809]

[Term]
id: HBP:HBP00052
name: AP-2 complex
def: "A heterotetrameric adapter protein complex involved in cargo-internalization during clathrin-mediated endocytosis. Composed of alpha and beta subunits (large adaptins), mu and sigma subunits (minor adaptins)." [pmid:27260836]
xref: go:GO:0030122

[Term]
id: HBP:HBP00053
name: Tau isoform F (441 aa)
def: "Longest tau isoform in human brain, most commonly used as the conventional tau." [pmid:17493042]
synonym: "microtubule-associated protein tau isoform 2" EXACT []
synonym: "2N4R" EXACT []
synonym: "htau40" EXACT [pmid:19226187]
xref: ncbiprotein:NP_005901
is_a: HBP:HBP00045 ! 4R tau

[Term]
id: HBP:HBP00054
name: Tau isoform Fetal-tau (352 aa)
def: "Human fetal tau isoform." [pmid:17493042]
synonym: "microtubule-associated protein tau isoform 4" EXACT []
synonym: "0N3R" EXACT []
synonym: "htau23" EXACT [pmid:7667312]
xref: ncbiprotein:NP_058525

[Term]
id: HBP:HBP00055
name: Tau isoform B (381 aa)
def: "Human brain tau isoform, derived from alternative splicing." [pmid:17493042]
synonym: "microtubule-associated protein tau isoform 7" EXACT []
synonym: "1N3R" EXACT []
synonym: "htau37" EXACT [pmid:22762014]
xref: ncbiprotein:NP_001190180
is_a: HBP:HBP00044 ! 3R tau

[Term]
id: HBP:HBP00056
name: Tau isoform D (383 aa)
def: "Human brain tau isoform, derived from alternative splicing." [pmid:17493042]
synonym: "microtubule-associated protein tau isoform 3" EXACT []
synonym: "0N4R" EXACT []
synonym: "htau24" EXACT [pmid:22762014]
xref: ncbiprotein:NP_058518
is_a: HBP:HBP00045 ! 4R tau

[Term]
id: HBP:HBP00057
name: Tau isoform C (410 aa)
def: "Human brain tau isoform, derived from alternative splicing." [pmid:17493042]
synonym: "microtubule-associated protein tau isoform 8" EXACT []
synonym: "2N3R" EXACT []
synonym: "htau39" EXACT [pmid:22762014]
xref: ncbiprotein:NP_001190181
is_a: HBP:HBP00044 ! 3R tau

[Term]
id: HBP:HBP00058
name: Tau isoform E (412 aa)
def: "Human brain tau isoform, derived from alternative splicing." [pmid:17493042]
synonym: "microtubule-associated protein tau isoform 5" EXACT []
synonym: "1N4R" EXACT []
synonym: "htau34" EXACT [pmid:22762014]
xref: ncbiprotein:NP_001116539
is_a: HBP:HBP00045 ! 4R tau

[Term]
id: HBP:HBP00059
name: Serpin-enzyme complex receptor
def: "PMID: 2160076" [pmid:15160835]
synonym: "SEC-R" EXACT []

[Term]
id: HBP:HBP00060
name: neuroinflammation
def: "inflammatory response in the brain and nervous tissue." [pmid:26306439]
xref: go:GO:0150076

[Term]
id: HBP:HBP00061
name: neurotoxicity
def: "happens when a biological, physical or chemical agent cause any adverse effect on the structure and function of the nerves system." [pmid:18440072]

[Term]
id: HBP:HBP00062
name: neurite retraction
def: "when the neurite is unable it outgrow and extend" [pmid:19022228]

[Term]
id: HBP:HBP00063
name: APP695
def: "the APP gene is located on chromosome 21 in humans with three major isoforms arising from alternative splicing [3]. These are APP695, APP751 and APP770 (containing 695, 751, and 770 amino acids, respectively)" [pmid:21214928]

[Term]
id: HBP:HBP00064
name: APP751
def: "the APP gene is located on chromosome 21 in humans with three major isoforms arising from alternative splicing [3]. These are APP695, APP751 and APP770 (containing 695, 751, and 770 amino acids, respectively)" [pmid:21214928]

[Term]
id: HBP:HBP00065
name: APP770
def: "the APP gene is located on chromosome 21 in humans with three major isoforms arising from alternative splicing [3]. These are APP695, APP751 and APP770 (containing 695, 751, and 770 amino acids, respectively)" [pmid:21214928]

[Term]
id: HBP:HBP00066
name: gamma-secretase
def: "gamma-secretase is a high molecular weight complex minimally composed of four components: presenilins (PS), nicastrin, anterior pharynx defective 1 (APH-1), and presenilin enhancer 2 (PEN-2)" [pmid:25565961]
xref: fplx:Gamma_secretase

[Term]
id: HBP:HBP00067
name: sAPP-alpha
def: "soluble amyloid precursor protein-alpha" [pmid:22491325]

[Term]
id: HBP:HBP00068
name: Excitotoxicity
def: "Excitotoxicity is defined as cell death resulting from the toxic actions of excitatory amino acids" [pmid:19343058]

[Term]
id: HBP:HBP00069
name: C31
def: "a fragment containing the last 31 amino acids of APP (called C31)" [pmid:21214928]

[Term]
id: HBP:HBP00070
name: Jcasp
def: "Additional gamma-cleavage further generates the fragment (called Jcasp) containing the region between gamma- and caspase-cleavage sites" [pmid:21214928]

[Term]
id: HBP:HBP00071
name: AICD
def: "APP intracellular domain" [pmid:21214928]

[Term]
id: HBP:HBP00072
name: p83
def: "APP alphaCTF and betaCTF are further cleaved by gamma-secretase to generate p83 and Abeta, respectively" [pmid:21214928]

[Term]
id: HBP:HBP00073
name: APP processing
def: "Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein (see:GO:0016485)" [pmid:21214928]

[Term]
id: HBP:HBP00074
name: AβOs
def: "soluble Aβ oligomers" [pmid:24685176]

[Term]
id: HBP:HBP00075
name: LMW amyloid oligomers
def: "The formation of AβOs starts from alterations in the conformation of monomeric Aβ, resulting in low molecular weight (LMW) dimers and trimers, followed by aggregation to soluble spherical oligomers consisted of 12–24 monomers." [pmid:18723507]

[Term]
id: HBP:HBP00076
name: amyloid-beta 40 oligomers
def: "Amyloid-beta oligomers composed specifically of amyloid-beta 40" [pmid:21209907]

[Term]
id: HBP:HBP00077
name: alternative splicing of APP gene
def: "The process of generating multiple mRNA molecules from a given set of exons by differential use of exons from the primary transcript(s) to form multiple mature mRNAs that vary in their exon composition (see:GO:0000380)" [pmid:22122372]

[Term]
id: HBP:HBP00078
name: E1 domain
def: "The ectodomains of APP and APLPs have two conserved regions called E1 and E2 (Fig. 1A), both of which have been proposed to contribute to dimerization" [pmid:21574595]

[Term]
id: HBP:HBP00079
name: E2 domain
def: "The ectodomains of APP and APLPs have two conserved regions called E1 and E2 (Fig. 1A), both of which have been proposed to contribute to dimerization" [pmid:21574595]

[Term]
id: HBP:HBP00080
name: P3 peptide
def: "Cleavage by α-secretase yields the nonamyloidogenic soluble 3-kDa peptide (p3) that does not form amyloid fibrils, whereas cleavage by β-secretase yields the amyloidogenic form Aβ1–40 or the longer, more fibrillogenic Aβ1–42" [pmid:22137428]

[Term]
id: HBP:HBP00081
name: C99
def: "a membrane associated C-terminal fragment consisting of 99 amino acids (C99)" [pmid:22122372]

[Term]
id: HBP:HBP00082
name: aMCI
def: "amnestic Mild Cognitive Impairement is a cognitive dysfunction that is associated with memory deficits" [pmid:18986241]

[Term]
id: HBP:HBP00083
name: mdMCI
def: "multi-domain Mild Cognitive Impairement is a cognitive dysfunction that is associated with more than one cognitive domain" [pmid:18986241]

[Term]
id: HBP:HBP00084
name: Tau isoform A (316 aa)
def: "Human brain tau isoform, derived from alternative splicing." [pmid:18986241]

[Term]
id: HBP:HBP00085
name: Tau C3
def: "Tau epitope cleaved at aspartic acid(421)." [pmid:18986241]

[Term]
id: HBP:HBP00086
name: Tau MN423
def: "Tau epitope truncated at glutamic acid(391)." [pmid:18986241]

[Term]
id: HBP:HBP00087
name: granular tau oligomers
def: "When the oligomer lengthens, it adapts a beta-sheet structure and transforms into a detergent-insoluble aggregate with granular appearance under Atomic Force Microscopy (AFM)" [pmid:28420982]

[Term]
id: HBP:HBP00088
name: Tau fibrils
def: "As these granular tau oligomers fuse together, they form tau fibrils, which ultimately form NFTs" [pmid:28420982]

[Term]
id: HBP:HBP00089
name: dense core plaques
def: "Dense-core plaques are fibrillar deposits of Abeta, showing all the classical properties of amyloid including beta-sheet secondary structure, while diffuse plaques are amorphous deposits" [pmid:17680701]

[Term]
id: HBP:HBP00090
name: Tau annular protofibrils
def: "A handful of proteins implicated in neurodegenerative diseases have been found to produce pore-like amyloid structures known as annular protofibrils (APFs)" [pmid:28420982]

[Term]
id: HBP:HBP00091
name: TOC1
def: "monoclonal antibody, named TOC1 (tau oligomeric complex 1), which selectively labels tau dimers and oligomers, but does not label filaments" [pmid:22817713]

[Term]
id: HBP:HBP00092
name: alpha-synuclein fibrils
def: "fibrillar aggregates of alpha-synuclein, found in Lewy bodies" [pmid:19892735]

[Term]
id: HBP:HBP00093
name: alpha-synuclein oligomers
def: "oligomeric aggregates of alpha-synuclein" [pmid:17374364]

[Term]
id: HBP:HBP00094
name: CLR01
def: "the Lys-specific molecular tweezer CLR01 has been shown to inhibit aggregation and toxicity of multiple amyloidogenic protein" [pmid:23183235]

[Term]
id: HBP:HBP00095
name: prefibrillar α-synuclein oligomers
def: " prefibrillar oligomers formed at early stages of α-syn assembly" [pmid:27075649]

[Term]
id: HBP:HBP00096
name: GA-AGE
def: "Glyceraldehyde-derived (GA) advanced glycation end products" [pmid: 16630055, pmid:15221334]

[Term]
id: HBP:HBP00097
name: TGM2 Isoform 3 (349 aa)
def: "Short isoform of tissue transglutaminase" [pmid:12578227]

[Term]
id: HBP:HBP00098
name: KXGS motif
def: "Conserved Tau phosphorylation motif. Part of the microtubule-binding region, phosphorylation of the serine in these motifs disrupts tau binding to the MT and serves to regulate tau-mediated MT assembly" [pmid:17304350, pmid:21215781]

[Term]
id: HBP:HBP00099
name: Corticobasal Degeneration
def: "CBD is a late-onset neurodegenerative disease involving the cerebral cortex and the basal ganglia, characterized by widespread deposition of hyperphosphorylated 4-repeat tau in neurons and glia, the latter as astrocytic plaques" [pmid:22057784]
is_a: HBP:HBP00233 ! 4R tauopathy

[Term]
id: HBP:HBP00100
name: paired helical filaments
def: "Component of NFT, consisting in a helical arrangement of tau protomers" [pmid:22496370, pmid:1706519]
part_of: GO:GO:0097418 ! neurofibrillary tangle

[Term]
id: HBP:HBP00101
name: straight filaments
def: "Component of NFT and ultrastructural polymorph of PHFs, with an assymetrical arrangement of the tau protomers" [pmid:16566606, pmid:28678775]
part_of: GO:GO:0097418 ! neurofibrillary tangle

[Term]
id: HBP:HBP00102
name: Alz50
def: "Murine IgM-class monoclonal antibody recognizing a specific conformational epitope adopted by tau during PHF formation" [pmid:16566606, pmid:8955115]

[Term]
id: HBP:HBP00103
name: O-GlcNAcylation
def: "A non-canonical glycosylation involving the attachment of single O-linked N-acetylglucosamine (O-GlcNAc) moieties to serine and threonine residues of cytoplasmic, nuclear, and mitochondrial proteins" [pmid:16630055]

[Term]
id: HBP:HBP00104
name: glycation
def: "The non-enzymatic reaction between the electrophilic carbonyl groups of a reducing sugar and the free amino groups of tau amino acids (especially of basic lysine or arginine residues) leading to the formation of  a ketoamine (Amadori product), an intermediate of AGE synthesis." [pmid:26655600]

[Term]
id: HBP:HBP00105
name: nitration
def: "Incorporation of a nitrogen dioxide (NO2) group in tyrosine residues (mostly) of proteins forming 3-nitrotyrosine (3-NT). A biomarker of cell, tissue and systemic nitrosative stress." [pmid:16566606]

[Term]
id: HBP:HBP00106
name: polyamination
def: "The reaction of polyamination by transglutaminases (TGs) involves a glutamine (Q) as acyl donor and a lysine (K) as acyl acceptor. It generates a (gamma)-glutamyl-(epsilon)-lysine isopeptide bond that causes protein cross-linking" [pmid:25974414]

[Term]
id: HBP:HBP00107
name: formylation
def: "The addition of a formyl functional group usually at the epsilon amino group of Lys residues" [pmid:21210655]

[Term]
id: HBP:HBP00108
name: Syndecan Family
def: "IterPro:IPR001050" [pmid:15241784]

[Term]
id: HBP:HBP00109
name: Bacterial invasion
def: "The process of bacteria invading a cell" [pmid:15241784]

[Term]
id: HBP:HBP00110
name: dopamine homeostasis
def: "Dopmine secrete in a homeostatic way" [pmid:26325389]

[Term]
id: HBP:HBP00111
name: PINK1-Park pathway
def: "The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo.pmid:23509287" [pmid:26182419]

[Term]
id: HBP:HBP00112
name: Glutamate excitotoxicity
def: "The excitotoxicity of Glutamate" [pmid:10196525]

[Term]
id: HBP:HBP00113
name: mitochondrial homeostasis
def: "The interplay between mitophagy and mitochondrial biogenesis." [pmid:25478815]

[Term]
id: HBP:HBP00114
name: ER mitochondria interorganellar crosstalk
def: "reference:pmid: 22577383" [pmid:25478815]

[Term]
id: HBP:HBP00115
name: Mitochondrial pathway
def: "reference:pmid: 22399422" [pmid:23313576]

[Term]
id: HBP:HBP00116
name: oxidative protein folding
def: "Oxidative protein folding is a process that is responsible for the formation of disulfide bonds between cysteine residues in proteins. The driving force behind this process is a redox reaction, in which electrons pass between several proteins and finally to a terminal electron acceptor." [pmid:26004228]

[Term]
id: HBP:HBP00117
name: mitochondrial motility
def: "The motility of mitochondria" [pmid:25565208]

[Term]
id: HBP:HBP00118
name: TIM/TOM complex
def: "The TIM/TOM complex is a protein complex in cellular biochemistry which translocates proteins produced from nuclear DNA through the mitochondrial membrane for use in oxidative phosphorylation. Only 13 proteins necessary for a mitochondrion are actually coded in mitochondrial DNA." [pmid:25565208]

[Term]
id: HBP:HBP00119
name: mitochondrial aggregation
def: "The aggregation of mitochondria" [pmid:25591737]

[Term]
id: HBP:HBP00120
name: mevalonate pathway
def: "The mevalonate pathway, also known as the isoprenoid pathway or HMG-CoA reductase pathway is an essential metabolic pathway present in eukaryotes, archaea, and some bacteria" [pmid:24695221]

[Term]
id: HBP:HBP00121
name: Dopaminergic cell groups
def: "UBERON:dopaminergic cell groups" [pmid:24695221]

[Term]
id: HBP:HBP00122
name: mitochondrial precursor protein
def: "The precursor protein of mitochondria" [pmid:26192197]

[Term]
id: HBP:HBP00123
name: PDR-1
def: "the nematode homologs of Parkin" [pmid:26430570]

[Term]
id: HBP:HBP00124
name: PINK-1
def: "the nematode homologs of PINK1" [pmid:26430570]

[Term]
id: HBP:HBP00125
name: skn-1
def: "the nematode homologus of Skn1" [pmid:25896323]

[Term]
id: HBP:HBP00126
name: ced-9
def: "the nematode homologus of Bcl-2" [pmid:25896323]

[Term]
id: HBP:HBP00127
name: lgg-1
def: "the nematode homologus of Lgg1" [pmid:25896323]

[Term]
id: HBP:HBP00128
name: clec-65
def: "the nematode homologus of Clec65" [pmid:25896323]

[Term]
id: HBP:HBP00129
name: clec-4
def: "the nematode homologus of Clec4" [pmid:25896323]

[Term]
id: HBP:HBP00131
name: exotoxin A
def: "exotoxin A is an exotoxin produced by Pseudomonas aeruginosa.It inhibits elongation factor-2. It does so by ADP-ribosylation of EF2. This then causes the elongation of polypeptides to cease." [pmid:25274306]

[Term]
id: HBP:HBP00132
name: mitochondrial DAMPs
def: "mitochondrial damage-associated molecular patterns" [pmid:20203610]

[Term]
id: HBP:HBP00133
name: IκB kinase
def: "The IκB kinase is an enzyme complex that is involved in propagating the cellular response to inflammation." [pmid:19880420]

[Term]
id: HBP:HBP00134
name: non-shivering thermogenesis
def: "Nonshivering thermogenesis was originally defined as a cold-induced increase in heat production not associated with the muscle activity of shivering. Recent research shows it to be a metabolic process located primarily in brown adipose tissue and controlled by the activity of the sympathetic nervous supply of this tissue.PMID: 6722594" [pmid:16224498]

[Term]
id: HBP:HBP00135
name: hsp-16
def: "the nematode homologus of hsp16" [pmid:22700657]

[Term]
id: HBP:HBP00136
name: heat shock proteins
def: "Heat shock proteins (HSP) are a family of proteins that are produced by cells in response to exposure to stressful conditions. They were first described in relation to heat shock," [pmid:15280428]

[Term]
id: HBP:HBP00137
name: high-calorie diets
def: "Diets with high calorie." [pmid:10412986]

[Term]
id: HBP:HBP00138
name: proteotoxicity
def: "To function, proteins must undergo a folding process that gives them the proper three dimensional structure. Numerous genetic and biochemical observations suggest that proteins that fail to fold properly impair cell function. This process, also referred to as proteotoxicity, is particularly important to the fate of non-renewable cells of long-lived organisms in which malfolded proteins (proteotoxins) can exert their deleterious influence over extended periods of time.reference:Proteotoxicity and Aging" [pmid:24149988]

[Term]
id: HBP:HBP00139
name: ss20399075
def: "A SNP located within the 3' UTR of FGF20, is significantly associated with PD risk" [pmid:15122513]

[Term]
id: HBP:HBP00140
name: Alpha-synuclein Oligomerization
def: "The formation of alpha-synuclein oligmer" [pmid:21296890]

[Term]
id: HBP:HBP00141
name: D6S253
def: "A microsatellite markers for Alzheimer’s and Parkinson’s Diseases" [pmid:9560156]

[Term]
id: HBP:HBP00142
name: D6S305
def: "A microsatellite markers for Alzheimer’s and Parkinson’s Diseases" [pmid:9560156]

[Term]
id: HBP:HBP00143
name: MTHFR,TT+AA
def: "In Parkinson's Disease, TT+AA is more frequent in MTHFR gene." [pmid:17914182]

[Term]
id: HBP:HBP00144
name: CAG repeats
def: "CAG repeats in genes." [pmid:22782013]

[Term]
id: HBP:HBP00145
name: Gastrointestinal dysfunctions
def: "The function of gastrotestine disorder." [pmid:24467967]

[Term]
id: HBP:HBP00146
name: olfactory epithelium
def: "UBERON:olfactory epithelium" [pmid:22691461]

[Term]
id: HBP:HBP00147
name: nasal cycle
def: "The nasal cycle is the often unnoticed alternating partial congestion and decongestion of the nasal cavities in humans and other animals. It is a physiological congestion of the nasal concha, also called the nasal turbinate, due to selective activation of one half of the autonomic nervous system by the hypothalamus." [pmid:23569018]

[Term]
id: HBP:HBP00148
name: hyposmia
def: "Hyposmia is a reduced ability to smell and to detect odors.Hyposmia might be a very early sign of Parkinson's disease. Hyposmia is also an early and almost universal finding in Alzheimer's disease and dementia with Lewy bodies. Lifelong hyposmia could be caused by Kallmann syndrome." [pmid:23933572]

[Term]
id: HBP:HBP00149
name: FMR1,(55-200 CGG)
def: "A premutation (PM) expansion (55-200 CGG) in the fragile X mental retardation gene 1 causes elevated messenger RNA and reduced fragile X mental retardation gene 1 protein." [pmid:24332449]

[Term]
id: HBP:HBP00150
name: pof14
def: "a new member of the F-box family, Pof14, which forms a canonical" [pmid:17016471]

[Term]
id: HBP:HBP00151
name: Neuroglia
def: "MeSH Unique ID: D009457" [pmid:19248803]

[Term]
id: HBP:HBP00152
name: GDNF Family
def: "The GDNF family of ligands (GFL) consists of four neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF), neurturin (NRTN), artemin (ARTN), and persephin (PSPN). GFLs have been shown to play a role in a number of biological processes including cell survival, neurite outgrowth, cell differentiation and cell migration. In particular signalling by GDNF promotes the survival of dopaminergic neurons." [pmid:10383122]

[Term]
id: HBP:HBP00153
name: Motor Neurons
def: "MeSH Unique ID: D009046" [pmid:10383122]

[Term]
id: HBP:HBP00154
name: noradrenergic neuron
def: "Cell:noradrenergic neuron" [pmid:10383122]

[Term]
id: HBP:HBP00155
name: midbrain dopaminergic neuron
def: "Cell:midbrain dopaminergic neuron" [pmid:10383122]

[Term]
id: HBP:HBP00156
name: Neurites
def: "A neurite or neuronal process refers to any projection from the cell body of a neuron." [pmid:23872421]

[Term]
id: HBP:HBP00157
name: GRB10,BPS domain
def: "BPS domain of protein GRB10" [pmid:25268761]

[Term]
id: HBP:HBP00158
name: common fragile site
def: "A chromosomal fragile site is a specific heritable point on a chromosome that tends to form a gap or constriction and may tend to break when the cell is exposed to partial replication stress.Based on their frequency, fragile sites are classified as common or rare.To date, more than 120 fragile sites have been identified in the human genome." [pmid:12874785]

[Term]
id: HBP:HBP00159
name: PARK7-alpha helices
def: "The alpja helices of PARK7 protein" [pmid:18707128]

[Term]
id: HBP:HBP00160
name: cleaved PINK1
def: "The cleaved part of Protein PINK1" [pmid:21138942]

[Term]
id: HBP:HBP00161
name: neurovascular unit
def: "The brain hyperaemia, or coupling, is accomplished by a group of cells, closely related to each other; called neurovascular unit (NVU). The neurovascular unit is composed by neurones, astrocytes, endothelial cells of blood-brain barrier (BBB), myocytes, pericytes and extracellular matrix components. reference:PMID: 24629161" [pmid:25136294]

[Term]
id: HBP:HBP00162
name: Muscles
def: "MeSH Unique ID: D009132" [pmid:21151955]

[Term]
id: HBP:HBP00163
name: Neural Stem Cell
def: "MeSH Unique ID: D058953" [pmid:22357600]

[Term]
id: HBP:HBP00164
name: Ventral Tegmental Area
def: "MeSH Unique ID: D017557" [pmid:16190884]

[Term]
id: HBP:HBP00165
name: Pars Compacta
def: "MeSH Unique ID: D065842" [pmid:16190884]

[Term]
id: HBP:HBP00166
name: proline-rich domain
def: "Correspounding to residues I151 to Q244 of the 441 aa tau isoform, separated into P1 and P2. Possible role in tau's functional stabilization through the reported intramolecular interaction of P2 with R1, R2 and R4 from the microtubule-binding region" [pmid:25974414, pmid:8068626, pmid:9190213]
synonym: "PRD" EXACT [pmid:26789759]
synonym: "P domain" EXACT [pmid:8068626]

[Term]
id: HBP:HBP00167
name: lys-2
def: "the nematode homologus of Lys2" [pmid:25896323]

[Term]
id: HBP:HBP00168
name: abf-2
def: "the nematode homologus of Abf2" [pmid:25896323]

[Term]
id: HBP:HBP00169
name: hydrophobic pocket of actin
def: " The lower cleft between domains 1 and 3 is lined by residues Tyr143, Ala144, Gly146, Thr148, Gly168, Ile341, Ile345, Leu346, Leu349, Thr351, and Met355, which are predominantly hydrophobic. This cleft constitutes the major binding site for most ABPs and also mediates important longitudinal contacts between actin subunits in the filament" [pmid:21314430]

[Term]
id: HBP:HBP00170
name: 310-helix
def: "The 310-helix is the fourth most common type of secondary structure in proteins after α-helices, β-sheets, and reverse turns (Barlow and Thornton 1988). Approximately 15%–20% of all helices in protein structures are 310-helices, which are commonly found as N- or C-terminal extensions to an α-helix (Barlow and Thornton 1988). 310-Helices in proteins are typically only three to five residues long compared with a mean of 10–12 residues for α-helices (Richardson and Richardson 1988)" [pmid:12761385]

[Term]
id: HBP:HBP00171
name: Amylin Antagonist AC253
def: "Amino Acid Sequence: Ac-Leu-Gly-Arg-Leu-Ser-Gln-Glu-Leu-His-Arg-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Asn-Thr-Tyr-NH2" [pmid:22500019]

[Term]
id: HBP:HBP00172
name: CDK5R1 p25
def: "The cyclin dependent kinase 5 regulatory subunit 1 (CDK5R1), also known as p35, is cleaved by Calpain to produce the p25 fragment" [pmid:10830966]
xref: BEL:"p(HGNC:CDK5R1, frag(99_307))"

[Term]
id: HBP:HBP00173
name: PTI-125
def: "PTI-125 is a small molecule that preferentially binds altered FLNA and restores its native conformation, restoring receptor and synaptic activities and reducing its alpha7nAChR/TLR4 associations and downstream pathologies" [pmid:28438486]

[Term]
id: HBP:HBP00174
name: alpha-4 beta-2 nAChR
def: "In addition to nAChRs forming from different subunit assemblages, stoichiometric study has shown that α4β2 nAChRs can form as either (α4)3(β2)2 or (α4)2(β2)3, the latter having a greater affinity for both nicotine and Ach" [pmid:24828779]

[Term]
id: HBP:HBP00175
name: alpha-7 beta-2 nAChR
def: "Accumulating evidence demonstrates that these α7 and β2 nAChR subunits can co-assemble to form functional α7β2 nAChRs in heterologous expression systems, and also under natural conditions in the brain (Figure 1)" [pmid:27179601]

[Term]
id: HBP:HBP00176
name: beta-2-containing nAChR
def: "The β2 subunit can couple with non-α4 subunits, including α2, α3 and α6 subunits to form functionally distinct nAChRs, but these receptors are much less densely expressed in the central nervous system relative to α4β2* nAChRs (*indicating potential assemblage of β2 subunits with non-α4 subunits)" [pmid:24828779]

[Term]
id: HBP:HBP00177
name: Abeta*56
def: "56 kDa soluble amyloid-β (Aβ) assembly" [pmid:16541076]

[Term]
id: HBP:HBP00178
name: protein aggregates
def: "Aggregates of proteins or fragments of proteins" [pmc:PMC2633703, pmid:23254192, pmid:12747895, pmid:23484434]
xref: sbo:SBO:0000543

[Term]
id: HBP:HBP00179
name: sAPP-gamma
def: "results from the cleavage of beta APP by gamma-secretase" [pmid:12105112]

[Term]
id: HBP:HBP00180
name: alpha-6-containing nAChR
def: "alpha6-containing receptors, which in brain occur as heteropentamers with beta2 and beta3 and are especially enriched in presynaptic nerve terminals in striatum (Champtiaux et al.,2002)" [pmid:28445721, pmid:19498417]

[Term]
id: HBP:HBP00181
name: phosphatase-activating domain
def: "Tau domain located in the N-terminal region encompassing residues 2-18. It activates phosphatase PP1 which dephosphorylates Ser9 in GSK3Beta and leads to its activation. In normal tau, both NTD and CTD are folded back in proximity to each other forming a 'paper-clip' conformation, which masks the PAD. Phosphorylation in the AT8 epitope, disrupts this normal conformational state, exposing the PAD by moving away the terminal domains." [pmid:26671985, pmid:28413156]

[Term]
id: HBP:HBP00182
name: cystein-dependent auto-acetylation
def: "Autocatalytic cysteine-mediated acetylation of Lys residues in the MTBR upon incubation of tau proteins with acetyl-CoA, possible even in absence of enzymatic activity.This activity may be suppressed when tau is bound to tubulin or MTs, but activated upon tau dissociation during pathological conditions that abrogate tau-MT interactions, thus allowing acetyl-CoA accessibility to free tau cysteines." [pmid:28002468, pmid:27383765]

[Term]
id: HBP:HBP00183
name: GVD bodies
def: "Pathological hallmarks of Alzheimer Disease, consisting in intraneuronal accumulations of large membrane-bound vacuoles. Associated with the late stages of disease progression, they were also shown to be immunopositive or GSK3Beta and SYK (Spleen Tyrosine Kinase)." [pmid:26501932]

[Term]
id: HBP:HBP00184
name: advanced glycation end product
def: "Advanced glycation end products (AGEs) are the production of Maillard reaction between carbohydrates and proteins. They cause neurotoxicity via production of ROS followed by an increase in expression of APP and amyloid beta. Recent analysis implicates them in tau phosphorylation." [pmid:28176663]

[Term]
id: HBP:HBP00185
name: long-term potentiation
def: "A long lasting enhancement in synaptic transmission between two neurons, most commonly studied in the synapse between the Schaffer collateral axons of the CA3 neurons and the CA1 pyramidal neurons of the hippocampus. Alongside the LTD (long-term depression) represent the two mechanisms of memory formation and storage. Impairment of this process in AD is caused by soluble oligmoeric amyloid beta." [pmid:27041503]

[Term]
id: HBP:HBP00186
name: proline-rich region 1
def: "Part of the wider proline-rich domain, divided between the projection and assembly domains, this region together with the MTBR mediate tau interaction and binding to F actin." [pmid:21757739]
part_of: HBP:HBP00166 ! proline-rich domain
part_of: HBP:HBP00050 ! projection domain

[Term]
id: HBP:HBP00187
name: proline-rich region 2
def: "Part of the wider proline-rich domain, divided between the projection and assembly domains, this region together with the MTBR mediate tau interaction and binding to F actin." [pmid:21757739]
part_of: HBP:HBP00166 ! proline-rich domain
part_of: HBP:HBP00188 ! assembly domain

[Term]
id: HBP:HBP00188
name: assembly domain
def: "Tau assembly domain consists of the second part of the proline-rich region (PR2), MTBR and CTD, corresponding to residues 199-441 of the canonical tau isoform." [pmid:21757739]

[Term]
id: HBP:HBP00189
name: CRL4 complex
def: "Cullin-RING E3 ubiquitin ligase complex 4, consisting of CUL4(A,B), DDB1 and CRBN." [pmid:27325702]

[Term]
id: HBP:HBP00190
name: APP, ACR
def: "Cytosolic region of APP, responsible for interacting with E3 ubiquitin ligases among other proteins." [pmid:27325702]

[Term]
id: HBP:HBP00191
name: tubulin detyrosination
def: "Detyrosination is a form of posttranslational modification that occurs on alpha-tubulin. It consists of the removal of the C-terminal tyrosine to expose a glutamate at the newly formed C-terminus. Promoted by Tau truncation in the Gln124 residue." [pmid:25974414]

[Term]
id: HBP:HBP00192
name: Microgliosis
def: "An intense reaction of microglia following CNS insult, characterized by active proliferation and retracted cellular processes. In AD, accumulation of Abeta can be a possible cause of such physiological phenomenon, as microglia is seen surrounding senile plaques. Abeta interaction with microglial pattern recognition receptors (PRRs) leads to NLRP3 inflammasome activation, production of toxic NOS and ROS and release of proinflammatory cytokines." [pmid:29121589]

[Term]
id: HBP:HBP00193
name: Astrogliosis
def: "Morphological and functional changes observed in astrocytes in the context of their physiological response to CNS trauma or injury caused by ischemia, stroke, autoimmune disorders and neurodegeneration." [pmid:29121589]

[Term]
id: HBP:HBP00194
name: CK1 superfamily
def: "The CK1 group of eukaryotic protein kinases are composed of seven CK1 isoforms (CK1α, CK1α2, CK1δ, CK1ε, CK1γ1, CK1γ2, and CK1γ3), two Tau–tubulin kinase isoforms (TTBK1 and TTBK2), and three VRK isoforms (VRK1, VRK2, and VRK3)" [pmid:25673844]

[Term]
id: HBP:HBP00195
name: alpha-4-containing nAChR
def: "nAChRs that bind radiolabeled nicotine with the highest afﬁnity contain a4 subunits (a4*-nAChR)" [pmid:21787755]

[Term]
id: HBP:HBP00196
name: alpha-4 beta-4 nAChR
def: "a4 subunits can also assemble with b4 subunits to form a4b4-nAChRs that have comparably high nicotine afﬁnity" [pmid:21787755]

[Term]
id: HBP:HBP00197
name: alpha-7-containing nAChR
def: "Another prominent nAChR subtype found in vertebrate central and autonomic nervous systems contains a7 subunits." [pmid:21787755]

[Term]
id: HBP:HBP00198
name: alpha-Bungarotoxin 
def: "Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake)." [pmid:21787755]

[Term]
id: HBP:HBP00199
name: alpha-3 beta-2 nAChR
def: "nAChRs containing the a3b2 subunit interface" [pmid:21787755]

[Term]
id: HBP:HBP00200
name: kappa-Bungarotoxin
def: "kappa-Bungarotoxin, a snake venom kappa-neurotoxin, is a potent neuronal nicotinic receptor antagonist (pmid:3359187)" [pmid:21787755, pmid:3359187]

[Term]
id: HBP:HBP00201
name: VU10010
def: "highly selective M4 (mAChR) allosteric potentiator. Chemical name: 3-Amino-N-[(4-chlorophenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide" [pmid:24511233, pmid:18059262]

[Term]
id: HBP:HBP00202
name: VU0456940
def: "M1-selective PAM that potentiates M1 (mAChR). Chemical name:1-[4,6-difluoro-1-[6-(1-methylpyrazol-4-yl)pyridin-3-yl]indol-3-yl]sulfonyl-3-(5-methyl-1,2-oxazol-3-yl)propan-2-one" [pmid:24511233]

[Term]
id: HBP:HBP00203
name: VU0152099
def: "selective M4 (mAChR) allosteric potentiator. Chemical name: 3-Amino-N-(1,3-benzodioxol-5-ylmethyl)-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide" [pmid:24511233]

[Term]
id: HBP:HBP00204
name: VU0029767
def: "selective M1(mAChR)-PAM. Chemical name: 2-(4-Ethoxyanilino)-N'-[(Z)-(2-oxonaphthalen-1-ylidene)methyl]acetohydrazide" [pmid:24590577]

[Term]
id: HBP:HBP00205
name: VU0090157
def: "selective M1(mAChR)-PAM. Chemical name: Cyclopentyl 3,4-dimethyl-6-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,6-dihydropyrimidine-5-carboxylate" [pmid:24590577]

[Term]
id: HBP:HBP00206
name: VU0184670
def: "M1(mAChR) allosteric agonists. Chemical name: Ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride" [pmid:24590577]

[Term]
id: HBP:HBP00207
name: 2-Bromohexadecanoic acid
def: "Inhibits Fyn localization in lipid rafts and subsequently inhibits the fyn-dependent Abeta redistribution and accumulation in lipid rafts, process linked with ADDL-induced cell death." [pmid:18096814]

[Term]
id: HBP:HBP00208
name: 20 S Proteasome
def: "The catalytic core of the 26 S proteasome system, responsible for tau degradation" [pmid:17954934, pmid:19145068]

[Term]
id: HBP:HBP00209
name: 3-3 dityrosine cross-linking
def: "An oxidation product consisting of covalent ortho-ortho coupling between two tyrosine residues formed as a conseguence to UV irradiation, gamma-irradiation, aging, exposure to oxygen free radicals, nitrogen dioxide, peroxynitrite, and lipid hydroperoxides.  ROS catalyzed by Cu ions are involved in the generation of these cross-links in amyloid beta oligomers to which they provide stability. Also involved in the stabilization of tau PHF. A potential biomarker of oxidative stress in AD." [pmid:16566606, pmid: 24351276]

[Term]
id: HBP:HBP00210
name: Braak_Stage I
def: "A disease propagation and progression model, composed of six stages of increasing pathological severity determined by the location of the tangle-bearing neurons and the amplitude of the pathophysiological changes. Transentorhinal stages I-II: correspond to clinically silent cases of very mildly affected subjects, showing no cognitive impairment. NFT are slowly and gradually developping." [pmid:28176663, pmid:7566337]

[Term]
id: HBP:HBP00211
name: Braak_Stage II
def: "A disease propagation and progression model, composed of six stages of increasing pathological severity determined by the location of the tangle-bearing neurons and the amplitude of the pathophysiological changes. Transentorhinal stages I-II: correspond to clinically silent cases of very mildly affected subjects, showing no cognitive impairment. NFT are slowly and gradually developping." [pmid:28176663, pmid:7566337]

[Term]
id: HBP:HBP00212
name: Braak_Stage III
def: "A disease propagation and progression model, composed of six stages of increasing pathological severity determined by the location of the tangle-bearing neurons and the amplitude of the pathophysiological changes.Limbic stages III-IV designate an incipient Alzheimer's disease, since due to the lack of neocortical destruction, stages III and IV do not meet the currently used criteria for neuropathologic diagnosis of AD.  Stage III is characterised by the destruction of the external principal stratum of the entorhinal laminae presenting considerable amounts of NFT and neuropil threads." [pmid:7566337]

[Term]
id: HBP:HBP00213
name: Braak_Stage IV
def: "A disease propagation and progression model, composed of six stages of increasing pathological severity determined by the location of the tangle-bearing neurons and the amplitude of the pathophysiological changes.Limbic stages III-IV designate an incipient Alzheimer's disease, since due to the lack of neocortical destruction, stages III and IV do not meet the currently used criteria for neuropathologic diagnosis of AD.  Stage IV is characterised by the destruction of the internal principal stratum of the entorhinal laminae presenting considerable amounts of NFT and neuropil threads. The destruction of entorhinal cellular layers interferes with the normal transfer of information between neocortex and hippocampus, manifesting as cognitive impairment and subtle personality changes." [pmid:7566337]

[Term]
id: HBP:HBP00214
name: Braak_Stage V
def: "A disease propagation and progression model, composed of six stages of increasing pathological severity determined by the location of the tangle-bearing neurons and the amplitude of the pathophysiological changes.neocortical stages V-VI correspond to fully developed Alzheimer's disease. These stages are characterized by large numbers of NFTs in all sections of cerebral cortex and present neocortical damage thus contributing to the development of the conventional neuropathological criteria for the clinical diagnosis of AD." [pmid:28176663, pmid:7566337]

[Term]
id: HBP:HBP00215
name: Braak_Stage VI
def: "A disease propagation and progression model, composed of six stages of increasing pathological severity determined by the location of the tangle-bearing neurons and the amplitude of the pathophysiological changes.neocortical stages V-VI correspond to fully developed Alzheimer's disease. These stages are characterized by large numbers of NFTs in all sections of cerebral cortex and present neocortical damage thus contributing to the development of the conventional neuropathological criteria for the clinical diagnosis of AD." [pmid:7566337]

[Term]
id: HBP:HBP00216
name: CagA peptide
def: "A peptide with sequence:GFPLKRHDGVDDLSKVG, originally synthesized by Helicobacter Pylori acting as a specific MARK kinase inhibitor, decreasing tau phosphorylation" [pmid:23666762, pmid:19966800]

[Term]
id: HBP:HBP00217
name: MARK4 isoform 2 (688 aa)
def: "Shortest isoform of Microtubule affinity regulating kinase 4 (MARK4) derived from alternatvie splicing. It is upregulated during the early stages of neuron differentiation." [pmid:16973293]

[Term]
id: HBP:HBP00218
name: NP_001387.2:p.Arg205del
def: "Loss of function mutant of DYRK1A isoform 1" [pmid:28167836]

[Term]
id: HBP:HBP00219
name: NP_001387.2:p.Glu239del
def: "Loss of function mutant of DYRK1A isoform 1" [pmid:28167837]

[Term]
id: HBP:HBP00220
name: PrP106-126
def: "Prion protein fragment 106-126. This peptide increases membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and oxygen production in monocytes and neutrophils. It also induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell lines. PrP (106–126) stimulates leucocyte migration in a dose-dependent manner. Inhibits tau phosphorylaton at Ser262. Seq = KTNMKHMAGAAAAGAVVGGLG" [pmid:22692785]

[Term]
id: HBP:HBP00221
name: Purkinje cell layer of cerebellar cortex
def: "The Purkinje cell layer lies just underneath the molecular layer of the cerebellar cortex. It contains the neuronal cell bodies of the Purkinje cells that are arranged side by side in a single layer. Candelabrum interneurons are vertically oriented between the Purkinje cells. Purkinje neurons are inhibitory and provide the output of the cerebellar cortex through axons that project into the white matter. Extensive dendritic trees from the Purkinje cells extend upward in a single plane into the molecular layer where they synapse with parallel fibers of granule cells." [pmid:29221819]

[Term]
id: HBP:HBP00222
name: Tau antibody, AGG5759
def: "Tau antibody with specificity for pSer262" [pmid:23666762]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00223
name: Tau antibody, Tau-13
def: "Tau murine monoclonal antibody with specificity for pSer262" [pmid:23666762]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00224
name: Tau epitope, 12E8
def: "Tau epitope consisting of pSer262 and pSer356" [pmid:22156579]

[Term]
id: HBP:HBP00225
name: Tau epitope, AT180
def: "Tau epitope consisting of pThr231" [pmid:22833681]

[Term]
id: HBP:HBP00226
name: Tau epitope, AT8
def: "Tau epitope consisting of pSer202, pThr205, pSer208, pSer199" [pmid:18239272]

[Term]
id: HBP:HBP00227
name: Tau epitope, CP13
def: "Tau epitope consisting of pSer202" [pmid:25331948]

[Term]
id: HBP:HBP00228
name: Tau epitope, PHF1
def: "Tau epitope consisting of pSer396, pSer404" [pmid:22156579]

[Term]
id: HBP:HBP00229
name: dystrophic neurite
def: "Dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation." [pmid:28877763]

[Term]
id: HBP:HBP00230
name: granular layer of cerebellar cortex
def: "The granular layer is the innermost layer of the cerebellar cortex. This layer contains densely packed small neurons, mostly granule cells. Some Golgi cells are found at the outer border. Granule neurons send parallel fibers to the upper molecular layer, where they synapse with Purkinje cell dendrites. Mossy fibers from the pontine nuclei in the white matter synapse with granule cell axons, Golgi cell axons and unipolar brush interneuron axons at cerebellar glomeruli in the granule cell layer" [pmid:29221819]

[Term]
id: HBP:HBP00231
name: molecular layer of cerebellar cortex
def: "The molecular layer is the outermost layer of the cerebellar cortex. It contains the parallel fibers of the granule cells, interneurons such as stellate and basket cells, and the dendrites of the underlying Purkinje cells" [pmid:29221819]

[Term]
id: HBP:HBP00232
name: Kalirin 7
def: "Isoform of KALRN protein" [pmid:27796283]

[Term]
id: HBP:HBP00233
name: 4R tauopathy
def: "Tauopathies characterized by a relatively higher presence of the 4R tau isoforms, such as Alzheimers Disease and Corticobasal Degeneration" [pmid:21427723]

[Term]
id: HBP:HBP00234
name: ACY-1215
def: "Ricolinostat is an orally bioavailable, specific inhibitor of histone deacetylase 6 (HDAC6) with potential antineoplastic activity. Ricolinostat selectively targets and binds to HDAC6, thereby disrupting the Hsp90 protein chaperone system through hyperacetylation of Hsp90 and preventing the subsequent aggresomal protein degradation. This leads to an accumulation of unfolded and misfolded ubiquitinated proteins and may eventually induce cancer cell apoptosis, and inhibition of cancer cell growth. HDAC6, a class II HDAC deacetylase located in the cytoplasm, appears to play a key role in the formation and activation of the aggresomes needed for degradation of misfolded proteins. Compared to non-selective HDAC inhibitor, ACY-1215 is able to reduce the toxic effects on normal, healthy cells." [pmid:24844691]
inverse_is_a: MESH:D000544 ! Alzheimer Disease

[Term]
id: HBP:HBP00235
name: APOE e3
def: "Interacts with tubulin binding repeat 1" [pmid:26751493]

[Term]
id: HBP:HBP00236
name: BAY61-3606
def: "A cell-permeable imidazopyrimidine compound that acts a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (IC50 = 10 nM) with no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src even at concentrations as high as 4.7 µM. Shown to inhibit Syk-mediated cellular functions in vitro and exhibit good oral bioavailability and in vivo effacacy in the treatment of various allgery and asthma conditions in rat models. Indirect inhibitory effect on GSK3B activity" [pmid:25331948]

[Term]
id: HBP:HBP00237
name: Biphenyl-4-yl-acrylohydroxamoc acids
def: "Chemical compund group acting as inhibitors of HDAC family proteins." [pmid:26890116]

[Term]
id: HBP:HBP00238
name: Brodmann (1909) area 36
def: "Ectorhinal area 36 is a subdivision of the cytoarchitecturally defined temporal region of cerebral cortex. With its medial boundary corresponding approximately to the rhinal sulcus it is located primarily in the fusiform gyrus. Cytoarchitecturally it is bounded laterally and caudally by the inferior temporal area 20, medially by the perirhinal area 35 and rostrally by the temporopolar area 38 (H) (Brodmann-1909). Together with Brodmann area 35, it comprises the perirhinal cortex." [pmid:23407988]

[Term]
id: HBP:HBP00239
name: C-30-27
def: "PCAF and NFkappaB inhibitor, showed anti-inflammatory properties and improved cognition" [pmid:25672970]

[Term]
id: HBP:HBP00240
name: C646
def: "Inhibitor of EP300 acetylase" [pmid:20869593]

[Term]
id: HBP:HBP00241
name: CA1 field of hippocampus
def: "Part of hippocampus proper bounded by CA2 and the subiculum, characterized by pyramidal neurons that receive projections from pyramidal neurons of CA3 via the Schaffer collaterals." [pmid:23407988]

[Term]
id: HBP:HBP00242
name: CA2 field of hippocampus
def: "Part of hippocampus proper bounded by areas CA3 and CA1, characterized by a narrow layer of large pyramidal cells, similar in size to CA3 pyramidal cells, but which lack the mossy fiber input from the dentate gyrus" [pmid:23407988]

[Term]
id: HBP:HBP00243
name: CA3 field of hippocampus
def: "Part of hippocampus proper bounded by the hilus of the dentate gyrus and area CA2, characterized by large pyramidal cells and a dense projection from dentate gyrus granule cell mossy fibers." [pmid:23407988]

[Term]
id: HBP:HBP00244
name: CA4 field of hippocampus
def: "The last of four regions in the cornu ammonis of the hippocampus and is also part of the hilus of the dentate gyrus. This area contains mostly mossy cells that receive inputs from the dentate gyrus and pyramidal cells in the CA3 region and also projects back to the dentate gyrus." [pmid:23407988]

[Term]
id: HBP:HBP00245
name: CGP3466B
def: "Inhibitor of GAPDH nitrosylation, abrogated Abeta induced tau acetylation and subsequent pathological impairments related to AD" [pmid:29559585]

[Term]
id: HBP:HBP00246
name: CM-414
def: "A dual inhibitor of PDE5 and HDACs, chronic treatment of Tg2576 mice, a well characterized AD mouse model, showed decreased Ab and Tau phsophorylation and inhibition of GSK3B activity." [pmid:27550730]

[Term]
id: HBP:HBP00247
name: DAPK, basic loop (BL) motif
def: "A structural motif of DAPK (Death-Associated Protein Kinase) positively regulating the kinase activity." [pmid:27133022]

[Term]
id: HBP:HBP00248
name: Histone H3
def: "One of the five main histone proteins of chromatin structure, acetylation at Lys 9 was positively linked with the transcriptional activation of various genes involved in neuro-regeneration following peripheral axonal injury, among which BDNF." [pmid:24686445]

[Term]
id: HBP:HBP00249
name: ID-8
def: "Inhibitor of GSK3Beta and DYRK1 kinases" [pmid:28884684]

[Term]
id: HBP:HBP00250
name: LDN-193594
def: "A synthetic derviative of 2,4-diaminothiazole serving as an inhibitor of CDK5 kinase acitivty and of tau PHF1 epitope phosphorylation" [pmid:23737518]
is_a: HBP:HBP00276 ! diaminothiazole

[Term]
id: HBP:HBP00251
name: LDN-193665
def: "A synthetic derviative of 2,4-diaminothiazole with a lesser powerful inhibitory effect on CDK5, but a potent inhibitor of Gsk3b" [pmid:23737518]
is_a: HBP:HBP00277 ! diaminothiazole

[Term]
id: HBP:HBP00252
name: LDN-213843
def: "Small molecule of the diaminothiazole class, acting as inhibitor of CDK5 and GSK3Beta kinases" [pmid:23737518]
is_a: HBP:HBP00278 ! diaminothiazole

[Term]
id: HBP:HBP00253
name: Long-Term Depression
def: "A gradual weakening of neuronal synaptic connections lasting hours or longer following a long patterned stimulus. Along with LTP (long term potentiation) is one of the main mechanisms of memory formation, more specifically of spatial memory. The mechanism involves an interplay of NMDA and AMPA glutamate receptors, with minimal intracellular calcium levels triggering a cellular cascade leading to the removal of the latter and an overall decrease of the glutammate receptors in the postsynaptic neurons, thus weakening the synapse." [pmid:22833681]

[Term]
id: HBP:HBP00254
name: Pathological Tau Spreading
def: "Pathological spreading pattern of tau into defined anatomycally interconnected brain regions during the progression of tauopathy." [pmid:29540553]

[Term]
id: HBP:HBP00255
name: PrPSc
def: "PrPSc (scrapie isoform of the prion protein) prions are the infectious agent behind diseases such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids (deer, elk, moose, and reindeer), as well as goat and sheep scrapie. PrPSc is an alternatively folded variant of the cellular prion protein, PrPC, which is a regular, GPI-anchored protein that is present on the cell surface of neurons and other cell types." [pmid:22692785, pmid:29414853]

[Term]
id: HBP:HBP00256
name: Tau Protein Secondary Structure, Turn
def: "A turn-like structure formed in tau as a conseguence of the phosphorylation of only Ser202 and Thr205 residues, protects against aggregation." [pmid:28784767]

[Term]
id: HBP:HBP00257
name: Tau antibody, RG7345
def: "RG7345 is a humanized monoclonal antibody targeting the tau phosphoepitope pS422. Tau phosphorylated at this site is considered a pathological form that has been linked to the relocalization of tau away from microtubules and toward the somato-dendritic compartment of the neuron." [pmid:26751493, pmid:10967355]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00258
name: RGFP966
def: "Selective inhibitor of HDAC3" [pmid:28771976]

[Term]
id: HBP:HBP00259
name: SL-327
def: "Inhibitor of MAP2K1/2 kinases activity in murine neuroblastoma cell line N2A" [pmid:24401760]

[Term]
id: HBP:HBP00260
name: Spinocerebellar Ataxia 11
def: "Spinocerebellar ataxia type 11 (SCA11) is characterized by progressive cerebellar ataxia and abnormal eye signs (jerky pursuit, horizontal and vertical nystagmus). Caused by mutations in the TTBK2 (Tau Tubulin Kinase 2) gene, is inherited in an autosomal dominant manner." [pmid:21548880]

[Term]
id: HBP:HBP00261
name: ST7612AA1
def: "A thiol derivative, pan-HDAC inhibitor" [pmid:27917100]

[Term]
id: HBP:HBP00262
name: Tau antibody, AGG5759
def: "Rabbit polyclonal antibody against tau pSer262, AstraZeneca" [pmid:23666762]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00263
name: Tau epitope, AD2
def: "Tau epitope consisting of pThr396 and pSer404" [pmid:11943212]
is_a: HBP:HBP00307 ! Tau epitope

[Term]
id: HBP:HBP00264
name: Tau epitope, AP422
def: "Tau epitope consisting of pSer422" [pmid:11943212]
is_a: HBP:HBP00307 ! Tau epitope

[Term]
id: HBP:HBP00265
name: Tau epitope, AT100
def: "Tau epitope consisting of pSer212 and pThr214" [pmid:22833681]
is_a: HBP:HBP00307 ! Tau epitope

[Term]
id: HBP:HBP00266
name: Tau epitope, AT270
def: "Tau epitope consisting of pThr181" [pmid:11943212]
is_a: HBP:HBP00307 ! Tau epitope

[Term]
id: HBP:HBP00267
name: Thiamet G
def: "Inhibitor of O-GlcNAcase (OGA)" [pmid:22833681]

[Term]
id: HBP:HBP00268
name: Thioflavin S
def: "Dye binding to PHF used in AD diagnostics" [pmid:7667312]

[Term]
id: HBP:HBP00269
name: Trithiocarbonates
def: "Chemical compound group of susbtrate competitive selective HDAC6 inhibitors" [pmid:18558669]

[Term]
id: HBP:HBP00270
name: Tubacin
def: "Inhibitor of HDAC6" [pmid:23487739]

[Term]
id: HBP:HBP00271
name: Tubastatin A
def: "Inhibitor of HDAC6 shown to also decrease tau hyperphosphorylation and Ab load" [pmid:24844691]

[Term]
id: HBP:HBP00272
name: USP14 Aptamer
def: "Inhibitory oligopeptide of the USP14, a deubiquitinating enzyme." [pmid:26041011]

[Term]
id: HBP:HBP00273
name: cholinergic neuron
def: "A neuron that uses acetylcholine as a vesicular neurotransmitter." [pmid:29221819]

[Term]
id: HBP:HBP00274
name: cerebral cortex
def: "The thin layer of gray matter on the surface of the cerebral hemisphere that develops from the telencephalon. It consists of the neocortex (6 layered cortex or isocortex), the hippocampal formation and the olfactory cortex." [pmid:29221819]

[Term]
id: HBP:HBP00275
name: crebinostat
def: "Inhibitor of HDAC6" [pmid:25546293]

[Term]
id: HBP:HBP00276
name: diaminothiazole
def: "Compound class with kinase inhibition properties, specifically for CDK5 and GSK3Beta" [pmid:23737518]

[Term]
id: HBP:HBP00277
name: entorhinal cortex layer 2
def: "Layer of the entorhinal cortex lying superficial to layer 3 and deep to layer 1. It is characterized by medium-to large sized stellate cells that are grouped into prominent clusters, particularly in the rostral entorhinal cortex." [pmid:27798139]

[Term]
id: HBP:HBP00278
name: granular layer of cerebellar cortex
def: "The granular layer is the innermost layer of the cerebellar cortex. This layer contains densely packed small neurons, mostly granule cells. Some Golgi cells are found at the outer border. Granule neurons send parallel fibers to the upper molecular layer, where they synapse with Purkinje cell dendrites. Mossy fibers from the pontine nuclei in the white matter synapse with granule cell axons, Golgi cell axons and unipolar brush interneuron axons at cerebellar glomeruli in the granule cell layer." [pmid:29221819]

[Term]
id: HBP:HBP00279
name: indirubin
def: "A powerful inhibitor of GSK3B" [pmid:11013232]

[Term]
id: HBP:HBP00280
name: isocarboxazide
def: "Inhibitor of tau aggregation" [pmid:26751493]

[Term]
id: HBP:HBP00281
name: isopentanyladenine
def: "Inhibitor of CKD5 activity" [pmid:8726973]

[Term]
id: HBP:HBP00282
name: maitotoxin
def: "Increases intracellular calcium levels, and induces the association of TGM2 with tau, positively affecting the activity of the former" [pmid:10537045]

[Term]
id: HBP:HBP00283
name: olomoucine
def: "Inhibitor of CKD5 activity" [pmid:8726973]

[Term]
id: HBP:HBP00284
name: oxazolidinedione
def: "Inhibitor of tau aggregation" [pmid:26751493]

[Term]
id: HBP:HBP00285
name: sudoxicam
def: "Inhibitor of tau aggregation" [pmid:26751493]

[Term]
id: HBP:HBP00286
name: thiohydantoin
def: "Inhibitor of tau aggregation" [pmid:26751493]

[Term]
id: HBP:HBP00287
name: thioxooxazolidine
def: "Inhibitor of tau aggregation" [pmid:26751493]

[Term]
id: HBP:HBP00288
name: tideglusib
def: "Irreversibly inhibits GSK3B activity" [pmid:22102280]

[Term]
id: HBP:HBP00289
name: Tau antibody, 6C5
def: "human monoclonal antibody that targets tau epitope 125-131" [pmid:28408124]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00290
name: Tau antibody, HT7
def: "mouse monoclonal antibody that targets tau epitope 159-163" [pmid:28408124]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00291
name: 6-O-sulfated heparin
def: "During synthesis the HS chains are selectively sulfated at the N, 6-O, and 3-O positions of the glucosamine (GlcNS) and at the 2-O position of the uronic acid residue by HS sulfotransferases and modified by C5-epimerization of glucuronic acid (GlcA) to iduronic acid (IdoA)" [pmid:24878958]

[Term]
id: HBP:HBP00292
name: 2-O-sulfated heparin
def: "During synthesis the HS chains are selectively sulfated at the N, 6-O, and 3-O positions of the glucosamine (GlcNS) and at the 2-O position of the uronic acid residue by HS sulfotransferases and modified by C5-epimerization of glucuronic acid (GlcA) to iduronic acid (IdoA)" [pmid:24878958]

[Term]
id: HBP:HBP00293
name: sonicated tau fibrils
def: "To make sonicated fibril samples, fibrillized protein was sonicated using a MiSonix Sonicator 4000 (QSonica, LLC) at 50% amplitude for 60 1 s pulses" [pmid:29686391]

[Term]
id: HBP:HBP00294
name: Tau antibody, 40E8
def: "human monoclonal antibody that targets tau epitope 195-212 (pS202 and pT205)" [pmid:28408124]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00295
name: Tau antibody, pS396
def: "rabbit polyclonal antibody that targets tau pS396" [pmid:28408124]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00296
name: Tau antibody, 4E4
def: "human monoclonal antibody that targets tau epitope 385-395" [pmid:28408124]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00297
name: Tau antibody, Tau46
def: "mouse monoclonal antibody that targets tau epitope 404-441" [pmid:28408124]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00298
name: cis p-tau
def: "The cis conformation of phosphorylated tau is considered to be the main pathogenic tau agent associated with AD neurological impairments. PIN1, a peptidyl-prolyl-cis-transe isomerase, catalizes the rotation of the peptidic bond directly before proline residues inducing a conversion toward the trans conformation, therefore reducing the presence of the pathogenic cis tau isomers." [pmid:23157676, pmid:25628064]

[Term]
id: HBP:HBP00299
name: MPT0G211
def: "MPT0G211 is a novel potent, selective HDAC6 inhibitor with IC50 of 0.291 nM, displays >1,000-fold selectivity over other HDAC isoforms; significantly inhibits tau phosphorylation on Ser396, Ser404, and phosphorylated tau (p-tau) aggregation, significantly attenuates apoptosis induced by p-tau, inhibits HDAC6/Hsp90 binding and causes subsequent proteasomal degradation of polyubiquitinated proteins; ameliorates learning and memory impairment in animal models of Alzheimer's disease, reduces the amount of phosphorylated tau in the hippocampal CA1 region; also demonstrates antiproliferative activity against human multiple myeloma RPMI 8226, U266, and NCI-H929 cells with no effect on normal bone marrow cells." [pmid:29844403]

[Term]
id: HBP:HBP00300
name: peripheral nervous system injury
def: "PNS injuries initiate a signaling cascade that induces neuroregeneration. This cascade involves activation of ERK, subsequently leading to the activation of PCAF (KAT2B), which in turn mediates histone 3 acetylation, paving the way for transcriptional activation of the key genes in the regeneration program." [pmid:24686445]

[Term]
id: HBP:HBP00301
name: Tau antibody, TNT1
def: "Murine monoclonal IgG recognizing the phosphatase-activating domain (PAD) of tau" [pmid:27260838]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00302
name: Tau antibody, TNT2
def: "Murine monoclonal IgG recognizing the phosphatase-activating domain (PAD) of tau" [pmid:27260838]
is_a: HBP:HBP00307 ! Tau antibody

[Term]
id: HBP:HBP00303
name: 8-nitro-cGMP
def: "One of the major endogenus cGMP derivatives, a class of second messengers in the nitric oxide signalling pathway. It modifies the target protein's cysteine residues via a stable sulfide bond through the NO group of the guanine base, in a post translational modification also known as S-guanylation, a process involved in the regulation of the physiological roles of several important proteins. The S-guanylation of tau was shown to block the aggregation process and the subsequent formation of tau oligomers." [pmid:28213625, pmid:27601475]

[Term]
id: HBP:HBP00304
name: Tau dimers
def: "A key intermediate product of tau oligomerization to PHF and NFT formation, they consist of covalently linked antiparallel tau monomers presenting disulfide cross links between cystein residues." [pmid:27373205, pmid:10899437]

[Term]
id: HBP:HBP00305
name: polysumoylation
def: "A post-translational modification consisting on the addition and covalent bonding of multiple SUMO (small ubiquitin-like modifiers) proteins to lysine residues of target proteins, mediating a wide range of physiological functions. Polysumoylation of APP was found to reduce the generation of amyloid beta peptides, while mono or under-sumoylation enhance Ab generation." [pmid:12506199]

[Term]
id: HBP:HBP00306
name: detyrosination
def: "Detyrosination is a form of posttranslational modification that occurs on alpha-tubulin. It consists of the removal of the C-terminal tyrosine to expose a glutamate at the newly formed C-terminus." [pmid:25974414]

[Term]
id: HBP:HBP00307
name: Tau antibody
def: "Antibodies for the Tau protein (HGNC:MAPT)" [pmid:28408124, pmid:27260838, pmid:26751493, pmid:23666762, pmid:23666762]

[Term]
id: HBP:HBP00308
name: Tau epitope
def: "Epitopes targed by antibodies for the Tau protein (HGNC:MAPT)" [pmid:28408124, pmid:27260838, pmid:26751493, pmid:23666762, pmid:23666762]

[Term]
id: HBP:HBP00309
name: S 24795
def: "A partial agonist at α7 nAChR" [pmid:18187166, pmid:18265960, pmid:18034231]
synonym: "2-[2-(4-Bromophenyl)-2-oxoethyl]-1-methylpyridinium iodide" EXACT []
xref: pubchem:9888248
xref: chemspider:8063920
xref: inchi:InChI=1S/C14H13BrNO.HI/c1-16-9-3-2-4-13(16)10-14(17)11-5-7-12(15)8-6-11;/h2-9H,10H2,1H3;1H/q+1;/p-1
xref: smiles:C[N+]1=CC=CC=C1CC(=O)C2=CC=C(C=C2)Br.[I-]

[Term]
id: HBP:HBP00310
name: GTS-21
def: "GTS-21 is a derivative of the natural product anabaseine that acts as a partial agonist at neural nicotinic acetylcholine receptors. It binds to both the α4β2 and α7 subtypes, but activates only the α7 to any significant extent." [pmid:25514383]
synonym: "3-[(3E)-3-[(2,4-dimethoxyphenyl)methylidene]-3,4,5,6-tetrahydropyridin-2-yl]pyridine" EXACT [drugbank:DB05708]
synonym: "GTS-21" EXACT [drugbank:DB05708]
synonym: "3-(4-hydroxy-2-methoxybenzylidene)anabaseine" EXACT [pmid:25514383]
synonym: "GTS 21" EXACT [pmid:25514383]
xref: chemspider:4470526
xref: pubchem:5310985
xref: drugbank:DB05708
xref: inchi:InChI=1S/C19H20N2O2/c1-22-17-8-7-14(18(12-17)23-2)11-15-5-4-10-21-19(15)16-6-3-9-20-13-16/h3,6-9,11-13H,4-5,10H2,1-2H3/b15-11+
xref: smiles:[H]\C(=C1\CCCN=C1C1=CN=CC=C1)C1=C(OC)C=C(OC)C=C1

[Term]
id: HBP:HBP00311
name: alpha-4 alpha-5 beta-2 nAChR
def: "nAChR subtype found in cortex, hippocampus and neostriatum" [pmid:19721446]
xref: BEL:"complex(p(HGNC:CHRNA4), p(HGNC:CHRNA5), p(HGNC:CHRNB2))"

[Term]
id: HBP:HBP00312
name: alpha-3 beta-4 nAChR
def: "nAChR subtype found in hippocampus, pineal gland and cerebellum" [pmid:19721446]
xref: BEL:"complex(p(HGNC:CHRNA3), p(HGNC:CHRNB4))"

[Term]
id: HBP:HBP00313
name: alpha-3 beta-3 beta-4 nAChR
def: "nAChR subtype found in habenula and interpeduncular nucleus" [pmid:19721446]

[Term]
id: HBP:HBP00314
name: alpha-6 beta-2 beta-3 nAChR
def: "nAChR subtype found in locus coeruleus, substantia nigra and neostriatum" [pmid:19721446]

[Term]
id: HBP:HBP00315
name: alpha-2 beta-2 nAChR
def: "nAChR subtype found in interpeduncular nucleus" [pmid:19721446]

[Term]
id: HBP:HBP00316
name: alpha-6 alpha-4 beta-2 beta-3 nAChR
def: "nAChR subtype found in neostriatum" [pmid:19721446]

[Term]
id: HBP:HBP00317
name: protein aggregation
def: "Protein aggregation occurs in vivo as a result of improper folding or misfolding" [pmid:11831622]

